The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications
Technology in Cancer Research & Treatment · 2025-06 · 24
DOI: 10.1177/15330338251331960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 10.04.2025. Verfasst von Kai Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DOD Peer Reviewed Cancer Research Program.
Abstract (Originalsprache)
This review summarizes the intricate relationship between the microbiome and cancer initiation and development. Microbiome alterations impact metabolic pathways, immune responses, and gene expression, which can accelerate or mitigate cancer progression. We examine how dysbiosis affects tumor growth, metastasis, and treatment resistance. Additionally, we discuss the potential of microbiome-targeted therapies, such as probiotics and fecal microbiota transplants, to modulate cancer metabolism. These interventions offer the possibility of reversing or controlling cancer progression, enhancing the efficacy of traditional treatments like chemotherapy and immunotherapy. Despite promising developments, challenges remain in identifying key microbial species and pathways and validating microbiome-targeted therapies through large-scale clinical trials. Nonetheless, the intersection of microbiome research and cancer initiation and development presents an exciting frontier for innovative therapies. This review offers a fresh perspective on cancer initiation and development by integrating microbiome insights, highlighting the potential for interdisciplinary research to enhance our understanding of cancer progression and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA.
- Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India.
- Al Mouwassat University Hospital, Damascus, Syria.
ORCID-Profile: Zainab Motiwala, Md Wasim Khan
Förderung
- DOD Peer Reviewed Cancer Research Program
Zitieren
APA
Xu, K., Motiwala, Z., Corona-Avila, I., Makhanasa, D., Alkahalifeh, L., & Khan, M. W. (2025). The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications. Technology in Cancer Research & Treatment, 24. https://doi.org/10.1177/15330338251331960
Vancouver
Xu K, Motiwala Z, Corona-Avila I, Makhanasa D, Alkahalifeh L, Khan MW. The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications. Technology in Cancer Research & Treatment. 2025;24. doi:10.1177/15330338251331960
BibTeX
@article{Xu2025,
author = {Xu, Kai and Motiwala, Zainab and Corona-Avila, Irene and Makhanasa, Dhruvi and Alkahalifeh, Leen and Khan, Md Wasim},
title = {The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
volume = {24},
doi = {10.1177/15330338251331960}
}
EUVIMED